Skip to main content
. 2015 Dec 1;53(4):173–182. doi: 10.5152/tao.2015.1014

Table 3.

FNAB recommendations according to ultrasonography and clinical findings (American Thyroid Association)

USG and clinical findings Nodule size recommended for FNAB Strength of recommendation

High risk in history
 Existent suspicious USG findings >5 mm Strongly recommended (A)
 Nonexistent suspicious USG findings >5 mm Controversial (I)
Abnormal cervical lymph node All nodules Strongly recommended (A)
Microcalcification in nodule ≥1 cm Recommended (B)
Solid nodule
 Hypoechoic >1 cm Recommended (B)
 Iso- or hyperechoic ≥1–1.5 cm Recommended (C)
Mixed cystic-solid nodule
 Existent suspicious USG findings ≥1.5–2 cm Recommended (B)
 Nonexistent suspicious USG findings ≥2 cm Recommended (C)
Spongioform nodule ≥2 cm Recommended (C)
Pure cystic nodule No FNAB indication (unless it is for therapeutic purpose) Not recommended (E)

FNAB: fine-needle aspiration biopsy; USG: ultrasonography